Analysis of the Patients Who Admitted To A Turkish Emergency Department During COVID-19 Pandemic Patients in pandemic hospital

Main Article Content

Ertuğrul Altınbilek
Derya Öztürk
Ceren Atasoy
Miray Özlem
Fevzi Yılmaz
Cemil kavalci


COVID-19, RT-PCR, Emergency Department


Background and aim: In this study, it was aimed to review patients who presented to a Turkish emergency department (ED) with fever and at least one symptom and finding of acute respiratory infection (cough, shortness of breath) in Sisli Hamidiye Etfal Education and Research Hospital Tertiary Medical Care Center during COVID-19 pandemic.

Methods: This retrospective, descriptive, observational study included patients presented between March 10, 2020 and April 25, 2020. The patients were classified into two groups according to RT-PCR test result: RT-PCR (+) and RT-PCR (-). The demographic characteristics and clinical endpoint-related factors were analyzed in the patients.

Results: The study included 840 patients; 461 men (54.9%) and 379 women (45.1%). RT-PCR test was positive in 345 patients (41.0%). The most common comorbidity was hypertension (HT) in 119 patients (34.5%); followed by diabetes mellitus (DM) in 61 patients (18.3%). At time of ED presentation, there was mild clinical manifestation in 72.2%, whereas moderate in 21.7% and severe in 6.1% of patients with positive RT-PCR testing. Of the patients with positive RT-PCR testing, 64 patients (18.6%) were discharged from ED while 255 patients (73.9%) were admitted to COVID clinic and 26 were admitted to COVID intensive care unit (ICU). Of the patients admitted, 299 patients (86.7%) were discharged while 46 patients (13.3%) died due to multi-organ failure (MOF) (50%), acute respiratory distress syndrome (ARDS) (32.6%), acute pulmonary embolism (APE) (10.9%) and acute coronary syndrome (ACS) (6.5%).

Conclusions: The RT-PCR positivity rate seemed lower in our study when compared to literature. In addition, mortality rate was lower in our study when compared to other countries.


Download data is not yet available.
Abstract 286 | PDF Downloads 103


1. Zhu N, Zhang D, Wang W Li X, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Eng J Med 2020; 382(8): 727-33. doi: 10.1056/ NEJMoa2001017.
2. World Health Organization (2020) Novel coronavirus (2019-nCoV). Situation Report 22. 11 February 2020. (accessed 15 july 2020).
3. Rothan, H.A, Byrareddy SN. The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. J Autoimmun 2020; 109: 102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
4. World Health Organization (2020) Novel Coronavirus (2019-nCoV). Situation Report 11. 31 January 2020. (accessed 15 july 2020).
5. Jin Y, Yang H, Ji W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020; 12(4): 372 doi: 10.3390/v12040372.
6. Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 2020; 368:m1165. doi: 10.1136/bmj.m1165.
7. Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan's Emergency Medical System to the COVID-19 Outbreak in Italy. Lancet 2020; 395(10227): e49-e50. doi: 10.1016/S0140-6736(20)30493-1. Epub 2020 Feb 28.
8. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
9. Guan W, Ni Z, Liang W, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10. Fang Y, Zhang H, Xie X, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 200432. doi: 10.1148/radiol.2020200432. Online ahead of print.
11. Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med 2020; 8(4):e20. doi: 10.1016/S2213-2600(20)30117-X. Epub 2020 Mar 11.
12. Zhang JJ, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7):1730-1741 doi: 10.1111/all.14238. Epub 2020 Feb 27.
13. Liu Y, Yan L, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infect Dis 2020; 20(6): 656-657. doi: 10.1016/S1473-3099(20)30232-2. Epub 2020 Mar 19.
14. Li Q, Guan X, Wu P, et al. N Engl J Med 2020;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Ja
15. Liang, W.H., et al., Clinical characteristics and outcomes of hospitalized patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China. Eur Respir J 2020; 55(6): 2000562. doi: 10.1183/13993003.00562-2020. Print 2020 Jun.
16. Richardson S, Hircsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323(20): 2052-2059. doi: 10.1001/jama.2020.6775.
17. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
18. Jian-Min Jin JM, Bai P He W, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health 2020; 8:152. eCollection 2020.
19. Lu R, Zhao X, Li J, et al. Lancet 2020; 395(10224): 565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.